Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S344000, C546S288000, C546S296000
Reexamination Certificate
active
06946479
ABSTRACT:
Compounds of Formula (I)are effective in the treatment of a microbial infection.
REFERENCES:
patent: 5358949 (1994-10-01), Tabusa et al.
patent: 5407948 (1995-04-01), Fey et al.
patent: 5849587 (1998-12-01), Hanauske-Abel et al.
patent: 6046219 (2000-04-01), Hanauske-Abel et al.
patent: 6080766 (2000-06-01), Hanauske-Abel et al.
patent: 2443714 (1975-03-01), None
Posner et al., “Diels-Alder cycloadditions using nucleophilic 2-pyridones. Regiocontrolled and sterocontrolled synthesis of unsaturated, bridged, bicyclic lactams”,J. of Organic Chem., 1992, vol. 57, No. 15, pp. 4088-4097.
Bush Rodney Dean
Warshakoon Namal Chithranga
Desai Naishadh N.
Morris Patricia L.
The Procter & Gamble & Company
Upite David V.
LandOfFree
N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3427057